Daniel Rutrick

Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study

Advances in Therapy · 2017 · First of 12 authors · 31 citations

18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies

Journal of Substance Use and Addiction Treatment · 2023 · First of 6 authors